Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAstraZeneca's Investigational COVID-19 Prevention Drug Reduces Risk of Infection in Immunocompromised Persons.AuthorsJennings, SydneySubjectsCOVID-19 vaccines; IMMUNOCOMPROMISED patients; ASTRAZENECA PLCPublicationPatient Care (Online), 2024, p4ISSN1939-1897Publication typeArticle